Researchers at the University of Pennsylvania have developed a generative artificial intelligence (AI) model that can create synthetic antimicrobial peptides (AMPs) with bacteria-killing potential.

Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, recently hosted its latest Pharma.ai summer updates webinar, the second event in ...

What if generative AI could design life-saving antibiotics, not just art and text? In a new Cell Biomaterials paper, Penn researchers introduce AMP-Diffusion, a generative AI tool used to create tens ...

Generative AI models such as the image generation AI 'Stable Diffusion' use an approach called the 'diffusion model.' OpenAI has devised an alternative to this diffusion model, an approach called ' ...